U-2940

Human B cell lymphoma. Established in 1991 from the pleural effusion of a 18-year-old woman with diffuse large B-cell lymphoma (DLBCL) after being diagnosed earlier with Hodgkin lymphoma and treated with chemotherapy; cells were described to bear microsatellite instability
Cell Type:
B cell
Tissue Origin:
blood
Species:
human
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Cell Characteristics:
Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
V X-005 88% 64% Plasmid (general) 2 µg 100 µl I/II/2b